What is NDC 70594-042?

70594-042 is the product NDC for Vancomycin, Vancomycin 1 g/200mL injection, solution, listed with the FDA by Xellia Pharmaceuticals USA LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Xellia Pharmaceuticals USA LLC, NDC labeler code 70594. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vancomycin?

8 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vancomycin NDC 70594-042 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70594-042Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70594-0042Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70594-042-02	7059400420270594004202	6 BAG in 1 CARTON (70594-042-02) / 200 mL in 1 BAG (70594-042-01)Marketed from Feb 15, 2019
70594-042-03	7059400420370594004203	12 BAG in 1 CARTON (70594-042-03) / 200 mL in 1 BAG (70594-042-01)Marketed from Feb 15, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vancomycin
Generic name (nonproprietary): vancomycin
Active ingredients: Vancomycin — 1 g/200mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Xellia Pharmaceuticals USA LLCNDC labeler code 70594
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 211962
Marketing start: Feb 15, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Glycopeptides (Chemical structure)
Identifiers: Product ID 70594-042_e49b6589-caca-4c8f-8c57-55a1ee7774ccSPL ID e49b6589-caca-4c8f-8c57-55a1ee7774ccSPL set ID 60bee69b-be70-412c-9e83-a24a0a8a5e7bRxCUI 1807508, 1807510, 1807511, 2118448, 2118449, 2387078, 2387079UNII 6Q205EH1VU
Pharmacologic class: Glycopeptide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470594004202 followed by a unit qualifier and the quantity

Package 70594-0042-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 23, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Vancomycin Injection is a glycopeptide antibacterial indicated in adult and pediatric patients (1 month and older) for the treatment of: Septicemia ( 1.1 ) Infective Endocarditis ( 1.2 ) Skin and Skin Structure Infections ( 1.3 ) Bone Infections ( 1.4 ) Lower Respiratory Tract Infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Vancomycin Injection and other antibacterial drugs, Vancomycin Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.6 ) 1.1 Septicemia Vancomycin Injection is indicated in adults and pediatric patients (1 month and older) for th…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70594-042

What is NDC 70594-042?: 70594-042 is the product NDC for Vancomycin, Vancomycin 1 g/200mL injection, solution, listed with the FDA by Xellia Pharmaceuticals USA LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vancomycin.
What is the active ingredient?: Vancomycin.
Who is the labeler?: Xellia Pharmaceuticals USA LLC, NDC labeler code 70594. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vancomycin?: 8 other product NDCs are listed under this name. See all Vancomycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Vancomycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Vancomycin	Vancomycin 750 mg/150mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-056	70594-0056-0270594-0056-03
Vancomycin	Vancomycin 1.75 g/350mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-058	70594-0058-02
Vancomycin	Vancomycin 1.25 g/250mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-057	70594-0057-02
Vancomycin	Vancomycin 500 mg/100mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-041	70594-0041-0270594-0041-03
Vancomycin	Vancomycin 1.5 g/300mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-043	70594-0043-02
Vancomycin	Vancomycin 2 g/400mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-044	70594-0044-02
Vancomycinvancomycin hydrochloride	Vancomycin hydrochloride 5 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sagent Pharmaceuticals	25021-157	25021-0157-99
Vancomycinvancomycin hydrochloride	Vancomycin hydrochloride 10 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sagent Pharmaceuticals	25021-158	25021-0158-99

Other NDCs under NDA 211962

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 211962
Product	Strength	Form · route	Labeler	Product NDC
Tyzavanvancomycin	Vancomycin 1.25 g/250mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9466
Tyzavanvancomycin	Vancomycin 1.75 g/350mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9467
Tyzavanvancomycin	Vancomycin 750 mg/150mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9468
Tyzavanvancomycin	Vancomycin 1.5 g/300mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9469
Tyzavanvancomycin	Vancomycin 2 g/400mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9470
Tyzavanvancomycin	Vancomycin 500 mg/100mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9471
Tyzavanvancomycin	Vancomycin 1 g/200mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9472
Vancomycin	Vancomycin 500 mg/100mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-041
Vancomycin	Vancomycin 1.5 g/300mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-043
Vancomycin	Vancomycin 2 g/400mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-044
Vancomycin	Vancomycin 750 mg/150mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-056
Vancomycin	Vancomycin 1.25 g/250mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-057
Vancomycin	Vancomycin 1.75 g/350mL	Injection, SolutionIntravenous	Xellia Pharmaceuticals USA LLC	70594-058